Statements (11)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:pharmaceuticals
|
| gptkbp:can_be_combined_with |
checkpoint inhibitors
|
| gptkbp:developed_by |
gptkb:Onco_Sec_Medical_Incorporated
|
| https://www.w3.org/2000/01/rdf-schema#label |
ONCS-102
|
| gptkbp:indication |
gptkb:Oncology
|
| gptkbp:is_tested_for |
Phase 2
|
| gptkbp:mechanism_of_action |
intratumoral delivery of plasmid DNA
|
| gptkbp:route_of_administration |
injection
|
| gptkbp:status |
gptkb:Clinical_Trials
|
| gptkbp:targets |
cancer cells
|
| gptkbp:type |
gptkb:immunotherapy
|